One of the biggest challenges facing efforts to scale up COVID-19 vaccination globally has been supply; there simply have not been enough vaccines to meet the overwhelming global demand. But that dynamic is changing quickly in some parts of the world .
This analysis shows that supply is set to outstrip demand for vaccines in six of the G7 countries by the end of the summer. These same countries have purchased enough doses to vaccinate their entire population and still have more than 1 billion doses left over, which could be used to reduce the spread of variants, reopen the global economy and end the global pandemic faster.
Meanwhile, demand is accelerating in other parts of the world and many countries are struggling to protect even their most vulnerable citizens.
Leaders of the G7and other countries with advanced vaccine programmes must take the following steps to ensure that vaccines do not sit unused while the virus remains unchecked in other parts of the world:
- Share doses to maximize global coverage.
- Fully fund the Access to COVID-19 Tools Accelerator (ACT-A) and COVAX.
- Raise global ambition to reach global herd immunity next year.
Download the report (PDF format)